 Connection
Colleen McIlvennan to Adult
This is a "connection" page, showing publications Colleen McIlvennan has written about Adult.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.362 |
|
|
|
-
McIlvennan CK, Jones J, Makic M, Meek PM, Chaussee E, Thompson JS, Matlock DD, Allen LA. Stress and Coping Among Family Caregivers of Patients With a Destination Therapy Left Ventricular Assist Device: A Multicenter Mixed Methods Study. Circ Heart Fail. 2021 10; 14(10):e008243.
Score: 0.045
-
McIlvennan CK, Wordingham SE, Allen LA, Matlock DD, Jones J, Dunlay SM, Swetz KM. Deactivation of Left Ventricular Assist Devices: Differing Perspectives of Cardiology and Hospice/Palliative Medicine Clinicians. J Card Fail. 2017 Sep; 23(9):708-712.
Score: 0.032
-
Jurgens PT, Allen LA, Ambardekar AV, McIlvennan CK. Chronic Norovirus Infections in Cardiac Transplant Patients. Prog Transplant. 2017 03; 27(1):69-72.
Score: 0.032
-
McIlvennan CK, Lindenfeld J, Kao DP. Sex differences and in-hospital outcomes in patients undergoing mechanical circulatory support implantation. J Heart Lung Transplant. 2017 01; 36(1):82-90.
Score: 0.031
-
Bui QM, Allen LA, Monte AA, Page RL, McIlvennan CK. Amphetamine-positive urine drug screens in the setting of mexiletine use: A case series. J Heart Lung Transplant. 2016 08; 35(8):1045-8.
Score: 0.031
-
McIlvennan CK, Jones J, Allen LA, Swetz KM, Nowels C, Matlock DD. Bereaved Caregiver Perspectives on the End-of-Life Experience of Patients With a Left Ventricular Assist Device. JAMA Intern Med. 2016 Apr; 176(4):534-9.
Score: 0.031
-
McIlvennan CK, Jones J, Allen LA, Lindenfeld J, Swetz KM, Nowels C, Matlock DD. Decision-making for destination therapy left ventricular assist devices: implications for caregivers. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2):172-8.
Score: 0.028
-
McIlvennan CK, Page RL, Ambardekar AV, Brieke A, Lindenfeld J. Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients. J Heart Lung Transplant. 2014 Dec; 33(12):1312-4.
Score: 0.028
-
Hahn EA, Walsh MN, Allen LA, Lee CS, Denfeld QE, Teuteberg JJ, Beiser DG, McIlvennan CK, Lindenfeld J, Klein L, Adler ED, Stehlik J, Ruo B, Bedjeti K, Cummings PD, Vela AM, Grady KL. Validity of Patient-Reported Outcomes Measurement Information System Physical, Mental, and Social Health Measures After Left Ventricular Assist Device Implantation and Implications for Patient Care. Circ Cardiovasc Qual Outcomes. 2023 02; 16(2):e008690.
Score: 0.012
-
Raymer DS, Allen LA, Chaussee EL, McIlvennan CK, Thompson JS, Fairclough DL, Dunlay SM, Matlock DD, Larue SJ. Health Literacy in Patients Considering a Left Ventricular Assist Device: Findings From the DECIDE-LVAD Trial. J Card Fail. 2022 08; 28(8):1318-1325.
Score: 0.012
-
Kanwar MK, McIlvennan CK, Lohmueller LC, Bailey SH, Rogers JG, Teuteberg J, Cowger J. Defining Optimal Outcomes in Patients with Left Ventricular Assist Devices. ASAIO J. 2021 04 01; 67(4):397-404.
Score: 0.011
-
Venechuk GE, Khazanie P, Page RL, Knoepke CE, Helmkamp LJ, Peterson PN, Pierce K, Thompson JS, Huang J, Strader JR, Dow TJ, Richards L, Trinkley KE, Kao DP, McIlvennan CK, Magid DJ, Buttrick PM, Matlock DD, Allen LA. An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trial. Am Heart J. 2020 11; 229:144-155.
Score: 0.010
-
Matlock DD, McIlvennan CK, Thompson JS, Morris MA, Venechuk G, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Blue L, Chaussee EL, Glasgow RE, Walsh MN, Allen LA. Decision Aid Implementation among Left Ventricular Assist Device Programs Participating in the DECIDE-LVAD Stepped-Wedge Trial. Med Decis Making. 2020 04; 40(3):289-301.
Score: 0.010
-
Peters LL, McIlvennan CK, Khazanie P. Evaluation and Management of BK Polyomavirus Viremia in Patients With a Heart Transplant. Prog Transplant. 2019 12; 29(4):367-370.
Score: 0.010
-
Kwon R, Allen LA, Scherer LD, Thompson JS, Abdel-Maksoud MF, McIlvennan CK, Matlock DD. The Effect of Total Cost Information on Consumer Treatment Decisions: An Experimental Survey. Med Decis Making. 2018 07; 38(5):584-592.
Score: 0.009
-
Paine AM, Allen LA, Thompson JS, McIlvennan CK, Jenkins A, Hammes A, Kroehl M, Matlock DD. Anchoring in Destination-Therapy Left Ventricular Assist Device Decision Making: A Mechanical Turk Survey. J Card Fail. 2016 Nov; 22(11):908-912.
Score: 0.008
-
Magid M, Jones J, Allen LA, McIlvennan CK, Magid K, Thompson JS, Matlock DD. The Perceptions of Important Elements of Caregiving for a Left Ventricular Assist Device Patient: A Qualitative Meta-Synthesis. J Cardiovasc Nurs. 2016 May-Jun; 31(3):215-25.
Score: 0.008
-
Thompson JS, Matlock DD, McIlvennan CK, Jenkins AR, Allen LA. Development of a Decision Aid for Patients?With Advanced Heart Failure Considering a Destination Therapy Left?Ventricular Assist Device. JACC Heart Fail. 2015 Dec; 3(12):965-76.
Score: 0.007
-
Iacovetto MC, Matlock DD, McIlvennan CK, Thompson JS, Bradley W, LaRue SJ, Allen LA. Educational resources for patients considering a left ventricular assist device: a cross-sectional review of internet, print, and multimedia materials. Circ Cardiovasc Qual Outcomes. 2014 Nov; 7(6):905-11.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|